BackRevelation Biosciences Overview

Revelation Biosciences Accounts Payable

Track Revelation Biosciences's accounts payable ($830K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$828203.00
32.50% YoYΔ $203145.00 vs prior year quarter

Peer average

Loading

Revelation Biosciences Accounts Payable History

Loading

Revelation Biosciences vs. peers: Accounts Payable Comparison

Loading

Revelation Biosciences Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Revelation Biosciences (REVB) FAQ

As of the most recent data (March 2026), REVB shows a accounts payable of $830K. That compares with $630K in the prior-year period — up 32.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, REVB's accounts payable is now $830K (was $630K) — a 32.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Revelation Biosciences is outperforming or lagging.

Tracking REVB's accounts payable over time shows whether Revelation Biosciences is scaling, shrinking, or reshaping that part of the business. The current reading is $830K That compares with $630K in the prior-year period — up 32.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Revelation Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $830K) with ownership activity and broader fundamentals.